 IVERIC Bio Inc NASDAQ: ISEE is trading significantly higher Friday after Apellis Pharmaceuticals Inc NASDAQ: APLS reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. Apellis said the Phase 3 DERBY study in geographic atrophy did not meet the primary endpoint of GA lesion growth. 